The impact of journal advertisements on prescribers of cholinesterase inhibitors.
作者信息
Sauer Justin, Howard Robert
机构信息
Maudsley Hospital, South London and Maudlsey NHS Trust, London, UK.
出版信息
Int J Geriatr Psychiatry. 2002 Oct;17(10):976-8. doi: 10.1002/gps.727.
DOI:10.1002/gps.727
PMID:12325061
Abstract
摘要
相似文献
1
The impact of journal advertisements on prescribers of cholinesterase inhibitors.
Int J Geriatr Psychiatry. 2002 Oct;17(10):976-8. doi: 10.1002/gps.727.
2
[Alzheimer dementia. Comparison of the effectiveness of cholinesterase inhibitors and gingko].
MMW Fortschr Med. 2001 Dec 13;143(51-52):40-1.
3
Featured CME topic: dementia. Medication update.
South Med J. 2001 Jul;94(7):678-81.
4
[Mechanisms of action of Alzheimer medications].
Duodecim. 2003;119(20):1959-66.
5
A case history illustrating how extended release cholinesterase inhibitors could improve management of Alzheimer's disease.
J Alzheimers Dis. 2003 Dec;5(6):477-8. doi: 10.3233/jad-2003-5608.
6
Medications for the treatment of Alzheimer's disease.
J Okla State Med Assoc. 2001 Aug;94(8):347-9.
7
Current treatments for Alzheimer's disease: cholinesterase inhibitors.
J Clin Psychiatry. 2003;64 Suppl 9:11-7.
8
Adherence to cholinesterase inhibitors in patients with Alzheimer's disease.
J Am Geriatr Soc. 2009 Feb;57(2):366-8. doi: 10.1111/j.1532-5415.2009.02075.x.
9
Anticholinesterases in Alzheimer's disease: a modest effect on moderately severe disease.
Prescrire Int. 2003 Dec;12(68):230-1.
10
Review of donepezil, rivastigmine, galantamine and memantine for the treatment of dementia in Alzheimer's disease in adults with Down syndrome: implications for the intellectual disability population.
Int J Geriatr Psychiatry. 2004 Jun;19(6):509-15. doi: 10.1002/gps.1077.
引用本文的文献
1
Print advertisements for Alzheimer's disease drugs: informational and transformational features.
Am J Alzheimers Dis Other Demen. 2013 Jun;28(4):355-62. doi: 10.1177/1533317513488912. Epub 2013 May 17.
Zotero 插件